Axsome's depression drug enters competitive market after U.S. approval
Go back to Axsome's depression drug enters competitive market after U.S. approval| (NASDAQ: AXSM) | Delayed: 250.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.50 | 52 Week High | $15.74 | |||
| Open | $250.50 | 52 Week Low | $5.37 | |||
| Day High | $250.50 | P/E | N/A | |||
| Day Low | $250.50 | EPS | $0.00 | |||
| Volume | 7,685 | |||||
